Telomerase-mediated telomere elongation from human blastocysts to embryonic stem cells

Journal of Cell Science

Volumn 127, Issue 4, 2014, Pages 752-762

  Zeng, Sicong ^a,b   Liu, Lvjun ^a,b   Sun, Yi ^a,b,c   Xie, Pingyuan ^a,b   Hu, Liang ^a,b,c   Yuan, Ding ^a,d   Chen, Dehua ^c   Ouyang, Qi ^a,b,c,d   Lin, Ge ^a,b,c,d   Lu, Guangxiu ^a,b,c,d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c Reproductive and Genetic Hospital of CITIC Xiangya   (China)

^d National Engineering Research Center of Human Stem Cells   (China)

Author keywords

Embryonic stem cells; Telomerase; Telomere; Wnt bcatenin signaling

Indexed keywords

EMBRYONIC STEM CELLS; TELOMERASE; TELOMERE; WNT-Β-CATENIN SIGNALING;

ANIMALS; BIOLOGICAL MARKERS; BLASTOCYST; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMATIN; EMBRYONIC STEM CELLS; GENOMIC INSTABILITY; HISTONES; HUMANS; METHYLATION; MICE; NEOPLASM TRANSPLANTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TERATOMA; WNT SIGNALING PATHWAY;

EID: 84894056654     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.131433     Document Type: Article

References (35)

1. Agarwal, S., Loh, Y. H., McLoughlin, E. M., Huang, J., Park, I. H., Miller, J. D., Huo, H., Okuka, M., Dos Reis, R. M., Loewer, S. et al. (2010).Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464, 292-296.
2. Allshire, R. C., Dempster,M. and Hastie, N. D. (1989). Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res. 17, 4611-4627.
3. Armstrong, L., Saretzki, G., Peters, H., Wappler, I., Evans, J., Hole, N., von Zglinicki, T. and Lako, M. (2005). Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells 23, 516-529.
4. Blackburn, E. H. (2001). Switching and signaling at the telomere. Cell 106, 661-673.
5. Blasco, M. A. (2005). Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging. EMBO J. 24, 1095-1103.
6. Blasco,M. A. (2007a). Telomere length, stemcells and aging. Nat. Chem. Biol. 3, 640-649.
7. Blasco, M. A. (2007b). The epigenetic regulation of mammalian telomeres. Nat. Rev. Genet. 8, 299-309.
8. Bongso, A., Fong, C. Y. and Gauthaman, K. (2008). Taking stem cells to the clinic: Major challenges. J. Cell. Biochem. 105, 1352-1360.
9. d'Adda di Fagagna, F., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N. P. and Jackson, S. P. (2003). A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198.
10. Ford, L. P., Zou, Y., Pongracz, K., Gryaznov, S. M., Shay, J. W. and Wright, W. E. (2001). Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells. J. Biol. Chem. 276, 32198-32203.
11. García-Cao, M., O'Sullivan, R., Peters, A. H., Jenuwein, T. and Blasco, M. A. (2004). Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet. 36, 94-99.
12. Gonzalo, S., Jaco, I., Fraga, M. F., Chen, T., Li, E., Esteller, M. and Blasco, M. A. (2006). DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol. 8, 416-424.
13. Hasegawa, K., Yasuda, S. Y., Teo, J. L., Nguyen, C., McMillan, M., Hsieh, C. L., Suemori, H., Nakatsuji, N., Yamamoto, M., Miyabayashi, T. et al. (2012). Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xenofree human pluripotent cell expansion. Stem Cells Transl. Med. 1, 18-28.
14. He, S., Nakada, D. and Morrison, S. J. (2009). Mechanisms of stem cell selfrenewal. Annu. Rev. Cell Dev. Biol. 25, 377-406.
15. Henson, J. D., Neumann, A. A., Yeager, T. R. and Reddel, R. R. (2002). Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610.
16. Hoffmeyer, K., Raggioli, A., Rudloff, S., Anton, R., Hierholzer, A., Del Valle, I., Hein, K., Vogt, R. and Kemler, R. (2012). Wnt/b-catenin signaling regulates telomerase in stem cells and cancer cells. Science 336, 1549-1554.
17. Huang, J., Wang, F., Okuka, M., Liu, N., Ji, G., Ye, X., Zuo, B., Li, M., Liang, P., Ge, W. W. et al. (2011). Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res. 21, 779-792.
18. Lin, G., Xie, Y., Ouyang, Q., Qian, X., Xie, P., Zhou, X., Xiong, B., Tan, Y., Li, W., Deng, L. et al. (2009). HLA-matching potential of an established human embryonic stem cell bank in China. Cell Stem Cell 5, 461-465.
19. Liu, Y., Snow, B. E., Hande, M. P., Yeung, D., Erdmann, N. J., Wakeham, A., Itie, A., Siderovski, D. P., Lansdorp, P. M., Robinson, M. O. et al. (2000). The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr. Biol. 10, 1459-1462.
20. Liu, L., Bailey, S. M., Okuka, M., Muñoz, P., Li, C., Zhou, L., Wu, C., Czerwiec, E., Sandler, L., Seyfang, A. et al. (2007). Telomere lengthening early in development. Nat. Cell Biol. 9, 1436-1441.
21. Marión, R. M., Strati, K., Li, H., Tejera, A., Schoeftner, S., Ortega, S., Serrano, M. and Blasco, M. A. (2009). Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141-154.
22. Marión, R. M., Schotta, G., Ortega, S. and Blasco, M. A. (2011). Suv4-20h abrogation enhances telomere elongation during reprogramming and confers a higher tumorigenic potential to iPS cells. PLoS ONE 6, e25680.
23. Muntoni, A. and Reddel, R. R. (2005). The first molecular details of ALT in human tumor cells. Hum. Mol. Genet. 14 Spec. No 2, R191-R196.
24. Niida, H., Matsumoto, T., Satoh, H., Shiwa, M., Tokutake, Y., Furuichi, Y. and Shinkai, Y. (1998). Severe growth defect in mouse cells lacking the telomerase RNA component. Nat. Genet. 19, 203-206.
25. Palm, W. and de Lange, T. (2008). How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42, 301-334.
26. Redaelli, S., Bentivegna, A., Foudah, D., Miloso, M., Redondo, J., Riva, G., Baronchelli, S., Dalprà, L. and Tredici, G. (2012). From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res. Ther. 3, 47.
27. Seimiya, H., Muramatsu, Y., Ohishi, T. and Tsuruo, T. (2005). Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Cancer Cell 7, 25-37.
28. Varela, E., Schneider, R. P., Ortega, S. and Blasco, M. A. (2011). Different telomere-length dynamics at the inner cell mass versus established embryonic stem (ES) cells. Proc. Natl. Acad. Sci. USA 108, 15207-15212.
29. West, M. D. and Vaziri, H. (2010). Back to immortality: the restoration of embryonic telomere length during induced pluripotency. Regen. Med. 5, 485-488.
30. Yang, S., Lin, G., Tan, Y. Q., Zhou, D., Deng, L. Y., Cheng, D. H., Luo, S. W., Liu, T. C., Zhou,X.Y.,Sun, Z. et al. (2008). Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosomes Cancer 47, 665-679.
31. Yang, S., Lin, G., Tan, Y. Q., Deng, L. Y., Yuan, D. and Lu, G. X. (2010). Differences between karyotypically normal and abnormal human embryonic stem cells. Cell Prolif. 43, 195-206.
32. Zalzman, M., Falco, G., Sharova, L. V., Nishiyama, A., Thomas, M., Lee, S. L., Stagg, C. A., Hoang, H. G., Yang, H. T., Indig, F. E. et al. (2010). Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature 464, 858-863.
33. Zeng, S. and Yang, Q. (2009). The MUS81 endonuclease is essential for telomerase negative cell proliferation. Cell Cycle 8, 2157-2160.
34. Zeng, S., Xiang, T., Pandita, T. K., Gonzalez-Suarez, I., Gonzalo, S., Harris, C. C. and Yang, Q. (2009). Telomere recombination requires the MUS81 endonuclease. Nat. Cell Biol. 11, 616-623.
35. Zhou, X., Meeker, A. K., Makambi, K. H., Kosti, O., Kallakury, B. V., Sidawy, M. K., Loffredo, C. A. and Zheng, Y. L. (2012). Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence. Carcinogenesis 33, 113-118.